Notice for iptacopan (Novartis Pharmaceuticals Australia Pty Ltd)
Active ingredients
iptacopan
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
hard gelatine capsules
Indication
Treatment of adult patients with complement 3 glomerulopathy (C3G)
Therapeutic area
Nephrology